The July Edition of Burjeel Holdings Feat Focus has been released. This month, we focused on bringing advanced care closer to the community through various projects. July witnessed our historic research milestone Suite Ride successfully returning to Earth after studying diabetes in microgravity. Currently, we are analyzing the gathered data to advance diabetes research on the ground.

Burjeel Medical City achieved two exceptional milestones in research. Paving a new path in clinical research, our medical team diagnosed a patient with a unique combination of two rare diseases, one of the first such reported cases globally. In addition, at BMC, the first patient in the UAE recruited for the global THAL-01 study, which is evaluating a novel iron chelator for patients with transfusion-dependent thalassemia, marking the first advancement in this field in over 20 years.

Enhancing healthcare access to communities in Al Dhahir, Al Ain, we integrated specialized surgical services at the Burjeel Day Surgery Center, allowing residents to receive expert care closer to home. We also launched the Burjeel Center for Interventional Pain Management, the first dedicated center of its kind in Dubai and the Northern Emirates, offering targeted solutions for pain management.

We also signed a strategic partnership with the Department of Municipalities and Transport (DMT) to support the well-being of employees, clients, and visitors of DMT and its affiliated entities.

Check out Feat Focus newsletter here to know how we are reaffirming our commitment to community-first healthcare.

Burjeel Brings Advanced Care Closer to Communities: Check Out July Feat Focus